imatinib mesylate has been researched along with Encephalitis, JC Polyomavirus in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Blum, S; Brouland, JP; Chalandon, Y; Comoli, P; Comte, D; Du Pasquier, R; Dunet, V; Livio, F; Opota, O; Spertini, O; Tirefort, Y | 1 |
1 other study(ies) available for imatinib mesylate and Encephalitis, JC Polyomavirus
Article | Year |
---|---|
Progressive multifocal leukoencephalopathy responsive to withdrawal of imatinib in a patient with FIP1L1-PDGFRA positive myeloid neoplasm.
Topics: Humans; Hypereosinophilic Syndrome; Imatinib Mesylate; Leukoencephalopathy, Progressive Multifocal; mRNA Cleavage and Polyadenylation Factors; Myeloproliferative Disorders; Neoplasms; Oncogene Proteins, Fusion; Receptor, Platelet-Derived Growth Factor alpha | 2020 |